Kalaris Therapeutics, Inc. (KLRS): 8-K filed May 12, 2026

Form type

8-K

Filing date

May 12, 2026

Accession number

0001193125-26-218240

Filer

Kalaris Therapeutics, Inc. (CIK 1754068)